Search research articles
Contact Us
Filters
Showing results (131-140 of 269) with videos related to
Page
of 27
Sort By:
Gut
|
January 7, 2011
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
Walter Reinisch, William J Sandborn, Daniel W Hommes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 11, 2010
Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab
William J Sandborn, Maria T Abreu, Geert D'Haens, et al.
Journal of Crohn'S & Colitis
|
September 20, 2022
Benefit of Risk-stratified Prophylactic Treatment on Clinical Outcome in Postoperative Crohn's Disease
Vincent Joustra, Joris van Sabben, Eline van der Does de Willebois, et al.
Inflammatory Bowel Diseases
|
May 4, 2019
Capsule Retention in Crohn's Disease: A Meta-analysis
Shabana F Pasha, Marco Pennazio, Emanuele Rondonotti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 11, 2006
Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial
Stefan Schreiber, Brian Feagan, Geert D'Haens, et al.
Journal of Crohn'S & Colitis
|
May 15, 2026
Hyperbaric oxygen therapy alters bowel perfusion and improves outcomes in patients with treatment-refractory ulcerative colitis: a prospective pilot trial
Lieven Mulders, Maarten Pruijt, Joep Van Oostrom, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 28, 2017
Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set
Christopher Ma, Remo Panaccione, Richard N Fedorak, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 24, 2025
Endoscopic Response to Subcutaneous Infliximab by Disease Location: A Post Hoc Analysis of the LIBERTY-CD Study
Bruce E Sands, Stefan Schreiber, Marla C Dubinsky, et al.
Journal of Crohn'S & Colitis
|
March 27, 2026
Timing matters: recommendations for outcome assessment in real-world evidence studies of Crohn's disease
Paula Leão Moreira, Axel Dignass, Maria Manuela Estevinho, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 9, 2024
Ozanimod in Patients With Moderate to Severe Ulcerative Colitis Naive to Advanced Therapies
Bruce E Sands, Geert D'Haens, Remo Panaccione, et al.
Page
of 27
Search research articles
Search
Showing results (131-140 of 269) with videos related to
Sort By:
Page
of 27
Gut
|
January 7, 2011
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
Walter Reinisch, William J Sandborn, Daniel W Hommes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 11, 2010
Certolizumab pegol in patients with moderate to severe Crohn's disease and secondary failure to infliximab
William J Sandborn, Maria T Abreu, Geert D'Haens, et al.
Journal of Crohn'S & Colitis
|
September 20, 2022
Benefit of Risk-stratified Prophylactic Treatment on Clinical Outcome in Postoperative Crohn's Disease
Vincent Joustra, Joris van Sabben, Eline van der Does de Willebois, et al.
Inflammatory Bowel Diseases
|
May 4, 2019
Capsule Retention in Crohn's Disease: A Meta-analysis
Shabana F Pasha, Marco Pennazio, Emanuele Rondonotti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 11, 2006
Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial
Stefan Schreiber, Brian Feagan, Geert D'Haens, et al.
Journal of Crohn'S & Colitis
|
May 15, 2026
Hyperbaric oxygen therapy alters bowel perfusion and improves outcomes in patients with treatment-refractory ulcerative colitis: a prospective pilot trial
Lieven Mulders, Maarten Pruijt, Joep Van Oostrom, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 28, 2017
Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set
Christopher Ma, Remo Panaccione, Richard N Fedorak, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 24, 2025
Endoscopic Response to Subcutaneous Infliximab by Disease Location: A Post Hoc Analysis of the LIBERTY-CD Study
Bruce E Sands, Stefan Schreiber, Marla C Dubinsky, et al.
Journal of Crohn'S & Colitis
|
March 27, 2026
Timing matters: recommendations for outcome assessment in real-world evidence studies of Crohn's disease
Paula Leão Moreira, Axel Dignass, Maria Manuela Estevinho, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 9, 2024
Ozanimod in Patients With Moderate to Severe Ulcerative Colitis Naive to Advanced Therapies
Bruce E Sands, Geert D'Haens, Remo Panaccione, et al.
Page
of 27